Burrage Capital Management is a health care-focused equity fund specializing in long-short strategies. The firm invests in both private and public companies, providing a unique longitudinal view of drug development across the biotech industry. Their investment approach spans the entire lifecycle of biotech companies, from early-stage startups to post-IPO entities.